Opendata, web and dolomites

REDOXIT

Reactive oxygen species (ROS) as Elixirs against chronic Disease: OXidative regulatory mechanisms In T cells and neutrophils.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 REDOXIT project word cloud

Explore the words cloud of the REDOXIT project. It provides you a very rough idea of what is the project "REDOXIT" about.

models    immune    human    germany    systemic    biology    health    ageing    mediated    sweden    drug    groups    diseases    candidate    stimulate    chronic    balanced    extend    anticipate    career    brings    inflammation    regulation    leaders    arthritis    exchange    small    population    friedrich    generate    enzyme    nox2    aston    universitat    tomorrow    biomarker    benefit    partite    ex    redoxis    cross    university    ab    modulators    researcher    biochemical    animal    science    expertise    networking    disease    drugs    immunology    oxygen    encourage    thiol    vivo    innovative    skills    interchange    area    uses    complementary    alexander    mix    species    oxidation    reactive    industry    identification    basic    transfer    relevance    edge    redox    surrey    uker    molecule    cells    autoimmunity    training    proposing    academia    uk    collaborative    cutting    lupus    reaching    industrial    ros    modulate    emergent    erythematosus    sle    vitro    tri   

Project "REDOXIT" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITY OF SURREY 

Organization address
address: Stag Hill
city: GUILDFORD
postcode: GU2 7XH
website: www.surrey.ac.uk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website https://www.surrey.ac.uk/redoxit
 Total cost 144˙000 €
 EC max contribution 144˙000 € (100%)
 Programme 1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge)
 Code Call H2020-MSCA-RISE-2014
 Funding Scheme MSCA-RISE
 Starting year 2015
 Duration (year-month-day) from 2015-07-01   to  2019-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITY OF SURREY UK (GUILDFORD) coordinator 40˙500.00
2    UNIVERSITATSKLINIKUM ERLANGEN DE (ERLANGEN) participant 58˙500.00
3    ASTON UNIVERSITY UK (BIRMINGHAM) participant 31˙500.00
4    REDOXIS AB SE (LUND) participant 13˙500.00

Map

 Project objective

We are proposing a four-year programme of knowledge transfer and networking between University of Surrey (SURREY, UK), Aston University (ASTON, UK), Friedrich-Alexander Universitat (UKER, Germany) and Redoxis AB (Redoxis, Sweden). The project targets an emerging area of biology, i.e. reactive oxygen species (ROS)-mediated regulation of immunology and ageing; it brings together the application of small molecule candidate drugs to generate ROS and uses innovative approaches to biomarker identification in models of chronic immune disease. This research has significant potential for application in human health and is of particular relevance to the ageing population. Training, knowledge transfer and skills exchange in this emergent area is important to extend the EU’s reach through cutting edge expertise. Interchange in this way will facilitate and promote early career researcher development into tomorrow’s research leaders. It will encourage new, cross-European collaboration between academia and industry. This tri-partite consortium brings together groups with very complementary expertise for knowledge exchange to benefit early career researchers: ASTON – in the biochemical analyses of ROS; SURREY in thiol oxidation and effects in vitro and ex vivo on and within immune cells relevant for biomarker development in chronic disease; UKER - in animal models of chronic diseases such as systemic lupus erythematosus (SLE) and arthritis; and Redoxis on development of novel drugs that stimulate production of ROS from the NOX2 enzyme as means to modulate chronic inflammation. The project objectives and challenges present a balanced mix between industrial application and basic science, with a focus on knowledge transfer and drug development. Through future collaborative funding, we anticipate far-reaching applications of redox modulators to manage chronic disease and increase the knowledge of both autoimmunity and ageing of the immune system.

 Deliverables

List of deliverables.
Winter School on cell analysis Other 2019-11-29 10:50:34
Summer School on advances in free radical research Other 2019-11-29 10:50:34
Open workshop on inter-sectoral drug development Other 2019-11-29 10:50:34

Take a look to the deliverables list in detail:  detailed list of REDOXIT deliverables.

 Publications

year authors and title journal last update
List of publications.
2018 Markus H. Hoffmann, Helen R. Griffiths
The dual role of ROS in autoimmune and inflammatory diseases: Evidence from preclinical models
published pages: , ISSN: 0891-5849, DOI: 10.1016/j.freeradbiomed.2018.03.016
Free Radical Biology and Medicine 2019-11-29
2018 Viktor Reshetnikov, Jonas Hahn, Christian Maueröder, Christine Czegley, Luis Enrique Munoz, Martin Herrmann, Markus H. Hoffmann, Andriy Mokhir
Chemical Tools for Targeted Amplification of Reactive Oxygen Species in Neutrophils
published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2018.01827
Frontiers in Immunology 9 2019-11-29
2017 Deborah Kienhöfer, Jonas Hahn, Julia Stoof, Janka Zsófia Csepregi, Christiane Reinwald, Vilma Urbonaviciute, Caroline Johnsson, Christian Maueröder, Malgorzata J. Podolska, Mona H. Biermann, Moritz Leppkes, Thomas Harrer, Malin Hultqvist, Peter Olofsson, Luis E. Munoz, Attila Mocsai, Martin Herrmann, Georg Schett, Rikard Holmdahl, Markus H. Hoffmann
Experimental lupus is aggravated in mouse strains with impaired induction of neutrophil extracellular traps
published pages: e92920, ISSN: 2379-3708, DOI: 10.1172/jci.insight.92920
JCI Insight 2/10 2019-11-29

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "REDOXIT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "REDOXIT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.3.)

TREND (2019)

Transition with Resilience for Evolutionary Development

Read More  

VIDEC (2020)

Visualizing Death Inducing Protein Complexes

Read More  

RADON (2020)

Irradiation driven nanofabrication: computational modelling versus experiment

Read More